Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation - TripCo Outstanding Awards (Details)

v3.22.4
Stock-Based Compensation - TripCo Outstanding Awards (Details) - 2019 Plan - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Stock Options      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Granted 0    
Exercised 0 0 0
Additional disclosures      
Unvested value not yet recognized $ 3,500    
Weighted average period the unrecognized compensation cost will be recognized 1 year    
Stock Options | Series A      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Outstanding beginning balance 1,129,000    
Forfeited/Cancelled (27,000)    
Outstanding ending balance 1,102,000 1,129,000  
Options exercisable 717,000    
WAEP      
Weighted average exercise price, options outstanding (in dollars per share) $ 7.20    
Weighted average exercise price, options forfeited/cancelled (in dollars per share) 28.62    
Weighted average exercise price, options outstanding (in dollars per share) 6.65 $ 7.20  
Weighted average exercise price, options exercisable (in dollars per share) $ 7.84    
Weighted average remaining contractual term outstanding 4 years 2 months 12 days    
Weighted average remaining contractual term exercisable 3 years 9 months 18 days    
Stock Options | Series B      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Exercised 0    
Forfeited/Cancelled 0    
Outstanding ending balance 2,400,000    
Stock Options | Series B | CEO      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Granted     573,000
Stock Options | Series A and B      
Additional disclosures      
Amount of share reserve 3,500,000    
Restricted Stock and Restricted Stock Units      
Additional disclosures      
Aggregate fair value $ 537 $ 2,800 $ 554
Restricted Stock and Restricted Stock Units | Series A and B      
Additional disclosures      
Unvested RSUs and MSUs (in shares) 2,200,000    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value $ 3.80